2nd Quarter - Report

TARPLIN, DOWNS & YOUNG, LLC for ASTRAZENECA

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

**see addendum pagePL 111-148 The Patient Protection and Affordable Care Act, implementation, health care reform, drug importation, follow-on biologics, 340b, comparative effectiveness, gift disclosure PL 112-144 - The Food and Drug Administration Safety and Innovation Act, implementation ***, no specific bills, PDUFA, antimicrobial resistance, importation, companion diagnostics, user fee sequester

LobbyistCovered position, as disclosed
RAISSA H DOWNS —
MICHELLE P EASTON —
ISAAC A FORDJOUR —
LINDA E TARPLIN —
JENNIFER B YOUNG —

Contacted: SENATE; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES

Medicare/Medicaid MMM

**see addendum pagePL 111-148 The Patient Protection and Affordable Care Act, PL 111-152 - The Reconciliation Act of 2010, implementation, Medicare and Medicaid Drug Reimbursement, 340b, Innovation Center H.R. 351/S. 351 - Protecting Seniors' Access to Medicare Act of 2013, IPAB repeal ***, no specific bill(s), Medicare and Medicaid Drug Reimbursement, Medicaid Rebate, Medicare Part D, Non-Interference, health care reform implementation, real-world evidence, AMP, Sunshine, conditions of participation

LobbyistCovered position, as disclosed
RAISSA H DOWNS —
MICHELLE P EASTON —
ISAAC A FORDJOUR —
LINDA E TARPLIN —
JENNIFER B YOUNG —

Contacted: SENATE; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES

Bills named: H.R. 351 (113th), S. 351 (113th)

Pharmacy PHA

**see addendum pagePL 112-144 - The Food and Drug Administration Safety and Innovation Act, implementation H.R. 2186 - Valid Compounding Act H.R. 1919 - Safeguarding America's Pharmaceuticals Act of 2013, track and trace S. 959 - Pharmaceutical Compounding Quality and Accountability Act, track and trace ***, no specific bill(s), Import Safety, Prescription Drug User Fee Act renewal, drug development policy, drug shortages, supply chain integrity, patent settlements

LobbyistCovered position, as disclosed
RAISSA H DOWNS —
MICHELLE P EASTON —
ISAAC A FORDJOUR —
LINDA E TARPLIN —
JENNIFER B YOUNG —

Contacted: HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); SENATE

Bills named: H.R. 1919 (113th), S. 959 (113th), H.R. 2186 (113th)

Budget/Appropriations BUD

**see addendum pagebudget resolution, reconciliation, deficit reduction H.R. 933, Consolidated and Further Continuing Appropriations Act of 2013 H.R. 325, debt ceiling H.R. 2410, Agriculture and Related Agencies Appropriations Act, 2014 H.Con.Res. 25, establishing budget for 2014 S.Con.Res. 8, establishing budget for 2014 S. 388, American Family Economic Protection Act of 2013, Sequester

LobbyistCovered position, as disclosed
RAISSA H DOWNS Prin. Dep. Asst. Sec. for Leg. - HHS; Dep. Asst.
MICHELLE P EASTON Chief Health Counsel, Sen. Cmte. On Finance;
ISAAC A FORDJOUR —
LINDA E TARPLIN Congressman Billy Tauzin
JENNIFER B YOUNG Asst. Sec. for Leg. - HHS; Dep. Asst. Sec. for Leg.

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 2410 (113th), H.R. 933 (113th), H.R. 325 (113th), S. 388 (113th), S.Con.Res. 8 (113th), H.Con.Res. 25 (113th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.